OptimalPlus electronic manufacturing data analysis platform

National Instruments acquires OptimalPlus

  • National Instruments announced a definitive agreement to acquire the Israeli company OptimalPlus, which specializes in data analysis software for the semiconductor, automotive and electronics industries.
  • The transaction, valued at $365 million, is expected to close early in the third quarter of 2020.

OptimalPlus offers a software platform that integrates seamlessly with other existing tools. This open platform combines Machine Learning tools with a global data infrastructure to perform real-time analysis of in-process product data and deliver information across the entire supply chain.

OptimalPlus, which was founded in 2005, employs approximately 240 people. The Israeli company had sales of $51 million in 2019. Its headquarters are located in Holon, Israel. It also has offices in Asia, Europe and the United States.

With this acquisition, National Instruments (NI) aims to expand its software solutions offering to provide user companies with key business information based on advanced data analysis software tools that can be used throughout the product development cycle and throughout the entire supply chain.

According to the Texan company, its activities and those of OptimalPlus are complementary in the semiconductor, automotive and electronics industries. For example, NI’s test systems are implemented on semiconductor production lines, while OptimalPlus’ software solutions analyse manufacturing and test data.

NI’s software solutions are primarily oriented towards the control and monitoring of automatic test systems, whereas the OptimalPlus software platform focuses on the analysis of test and manufacturing data.

The combination of their solutions is designed to provide information on manufactured products to improve quality, optimize process efficiency and reduce time to market.

The acquisition of OptimalPlus by National Instruments is subject to customary closing conditions, including regulatory approval.